Targeting IRE1 with small molecules counteracts progression of atherosclerosis

Autor: Umut Inci Onat, Pelin Telkoparan Akillilar, Christian Weber, Ozlem Tufanli, Syed M. Hamid, Diego Acosta-Alvear, Peter Walter, Ebru Erbay, Ismail Çimen, Begüm Kocatürk
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Male
Chemokine
Aging
Unclassified drug
Mouse
Inflammasomes
Interleukin-1beta
Monocyte chemotactic protein 1
Apoptosis
Endoplasmic Reticulum
Inbred C57BL
Cardiovascular
Steady state
Unfolded protein response
Mice
In vivo study
Homeostasis
2.1 Biological and endogenous factors
Bone marrow derived macrophage
Aetiology
Disease course
Cells
Cultured

Protein inhibitor
Priority journal
Metaflammation
Atherosclerotic plaque
Multidisciplinary
Cultured
biology
Kinase
Th1 cell
Messenger RNA
Interleukin 1beta
Interleukin-18
STF 083010
Hyperlipoproteinemia type 3
Inflammasome
Atherogenesis
Endoplasmic Reticulum Stress
Gelatinase B
Cell biology
Hyperlipidemia
Lipotoxicity
PNAS Plus
Disease Progression
Endoplasmic reticulum stress
Apolipoprotein E
medicine.symptom
Animal cell
medicine.drug
Signal Transduction
Biotechnology
Human
Cells
Inflammation
RNA sequence
Protein Serine-Threonine Kinases
Article
Mouse model
Small Molecule Libraries
03 medical and health sciences
Immune system
Apolipoproteins E
inflammasome
medicine
Animals
Calgranulin A
Animal model
Animal experiment
Immune response
Endoplasmic reticulum
Macrophages
Membrane Proteins
Gene targeting
Interleukin 18
Atherosclerosis
Nonhuman
Lipid blood level
Mice
Inbred C57BL

030104 developmental biology
Human cell
Immunology
Unfolded Protein Response
biology.protein
X box binding protein 1
Gene expression
Protein IRE1
Reactive oxygen metabolite
Controlled study
Zdroj: Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, vol 114, iss 8
Popis: Metaflammation, an atypical, metabolically induced, chronic low-grade inflammation, plays an important role in the development of obesity, diabetes, and atherosclerosis. An important primer for metaflammation is the persistent metabolic overloading of the endoplasmic reticulum (ER), leading to its functional impairment. Activation of the unfolded protein response (UPR), a homeostatic regulatory network that responds to ER stress, is a hallmark of all stages of atherosclerotic plaque formation. The most conserved ER-resident UPR regulator, the kinase/endoribonuclease inositol-requiring enzyme 1 (IRE1), is activated in lipid-laden macrophages that infiltrate the atherosclerotic lesions. Using RNA sequencing in macrophages, we discovered that IRE1 regulates the expression of many proatherogenic genes, including several important cytokines and chemokines. We show that IRE1 inhibitors uncouple lipid-induced ER stress from inflammasome activation in both mouse and human macrophages. In vivo, these IRE1 inhibitors led to a significant decrease in hyperlipidemia-induced IL-1 beta and IL-18 production, lowered T-helper type-1 immune responses, and reduced atherosclerotic plaque size without altering the plasma lipid profiles in apolipoprotein E-deficient mice. These results show that pharmacologic modulation of IRE1 counteracts metaflammation and alleviates atherosclerosis.
Databáze: OpenAIRE